These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36989901)
1. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics. Ghosh M; Rana S Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901 [TBL] [Abstract][Full Text] [Related]
2. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells. Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538 [TBL] [Abstract][Full Text] [Related]
3. The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation. Buelli S; Imberti B; Morigi M Nephron; 2024; 148(10):712-723. PubMed ID: 38452744 [TBL] [Abstract][Full Text] [Related]
5. New concepts on the therapeutic control of complement anaphylatoxin receptors. Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324 [TBL] [Abstract][Full Text] [Related]
6. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2. Das A; Ghosh M; Gupta PK; Rana S J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188 [TBL] [Abstract][Full Text] [Related]
7. Anaphylatoxins: their role in bacterial infection and inflammation. Haas PJ; van Strijp J Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401 [TBL] [Abstract][Full Text] [Related]
8. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Li XX; Clark RJ; Woodruff TM Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293 [TBL] [Abstract][Full Text] [Related]
9. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379 [TBL] [Abstract][Full Text] [Related]
10. C4a: An Anaphylatoxin in Name Only. Barnum SR J Innate Immun; 2015; 7(4):333-9. PubMed ID: 25659340 [TBL] [Abstract][Full Text] [Related]
11. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins. Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960 [TBL] [Abstract][Full Text] [Related]
12. [Complement activation and inflammation]. Abe M Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666 [TBL] [Abstract][Full Text] [Related]
13. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). Cain SA; Monk PN J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063 [TBL] [Abstract][Full Text] [Related]
14. Rational design of antibody-like peptides for targeting the human complement fragment protein C5a. Ghosh M; Shadangi S; Rana S Proteins; 2024 Apr; 92(4):449-463. PubMed ID: 37933678 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2. Zaal A; van Ham SM; Ten Brinke A Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077 [TBL] [Abstract][Full Text] [Related]
16. C5aR2 receptor: The genomic twin of the flamboyant C5aR1. Das A; Gupta PK; Rana S J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039 [TBL] [Abstract][Full Text] [Related]
17. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg. Bajic G; Yatime L; Klos A; Andersen GR Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394 [TBL] [Abstract][Full Text] [Related]
18. The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity. Li XX; Lee JD; Kemper C; Woodruff TM J Immunol; 2019 Jun; 202(12):3339-3348. PubMed ID: 31160390 [TBL] [Abstract][Full Text] [Related]
19. C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10. Mödinger Y; Rapp A; Pazmandi J; Vikman A; Holzmann K; Haffner-Luntzer M; Huber-Lang M; Ignatius A J Cell Mol Med; 2018 Dec; 22(12):6002-6014. PubMed ID: 30247799 [TBL] [Abstract][Full Text] [Related]
20. Complement C5a Receptor 1 Exacerbates the Pathophysiology of Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO mBio; 2018 Jan; 9(1):. PubMed ID: 29362231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]